{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T12:23:25Z","timestamp":1762259005729,"version":"build-2065373602"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2304803, 2021YFC2301801","2022YFC2304803, 2021YFC2301801","2022YFC2304803, 2021YFC2301801","2022YFC2304803, 2021YFC2301801","2022YFC2304803, 2021YFC2301801","2022YFC2304803, 2021YFC2301801","2022YFC2304803, 2021YFC2301801","2022YFC2304803, 2021YFC2301801"],"award-info":[{"award-number":["2022YFC2304803, 2021YFC2301801","2022YFC2304803, 2021YFC2301801","2022YFC2304803, 2021YFC2301801","2022YFC2304803, 2021YFC2301801","2022YFC2304803, 2021YFC2301801","2022YFC2304803, 2021YFC2301801","2022YFC2304803, 2021YFC2301801","2022YFC2304803, 2021YFC2301801"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immun Ageing"],"DOI":"10.1186\/s12979-025-00543-7","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:22:51Z","timestamp":1762255371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential immune profiles in elderly patients with non-severe versus severe SARS-CoV-2 omicron variant infection: dysregulation of antibody responses and B-cell subsets"],"prefix":"10.1186","volume":"22","author":[{"given":"Xue","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanjuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junlian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"issue":"1","key":"543_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-00828-4","volume":"5","author":"N Siles Alvarado","year":"2025","unstructured":"Siles Alvarado N, Schuler M, Maguire C, Amengor DA, Nguyen AW, Wilen RE, et al. SARS-CoV-2 humoral immune responses in convalescent individuals over 12 months reveal severity-dependent antibody dynamics. Commun Med. 2025;5(1):149.","journal-title":"Commun Med"},{"issue":"4","key":"543_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106138","volume":"88","author":"LJ Sun","year":"2024","unstructured":"Sun LJ, Man QH, Zhang H, Xia S, Lu L, Wang XL, et al. Strong cross immune responses againstsarbecoviruses but not merbecoviruses in SARS-CoV-2 BA.5\/BF.7-infected individuals with or withoutinactivated COVID-19 vaccination. J Infect. 2024;88(4):106138.","journal-title":"J Infect"},{"issue":"1","key":"543_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-024-00426-3","volume":"21","author":"S Agrawal","year":"2024","unstructured":"Agrawal S, Tran MT, Jennings TSK, Soliman MMH, Heo S, Sasson B, et al. Changes in the innateimmune response to SARS-CoV-2with advancing age in humans. Immun Ageing. 2024;21(1):21.","journal-title":"Immun Ageing"},{"issue":"9","key":"543_CR4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00011-020-01372-8","volume":"69","author":"GH Meftahi","year":"2020","unstructured":"Meftahi GH, Jangravi Z, Sahraei H, Bahari Z. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of inflame-aging. Inflamm Res. 2020;69(9):825\u201339.","journal-title":"Inflamm Res"},{"issue":"26","key":"543_CR5","doi-asserted-by":"publisher","first-page":"9194","DOI":"10.1073\/pnas.0503280102","volume":"102","author":"DJ Rossi","year":"2005","unstructured":"Rossi DJ, Bryder D, Zahn JM, Ahlenius H, Sonu R, Wagers AJ, et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci U S A. 2005;102(26):9194\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"543_CR6","doi-asserted-by":"publisher","first-page":"7446","DOI":"10.4049\/jimmunol.174.11.7446","volume":"174","author":"K Naylor","year":"2005","unstructured":"Naylor K, Li GJ, Vallejo AN, Lee WW, Koetz K, Bryl E, et al. The influence of age on T cell generation and TCR diversity. J Immunol. 2005;174(11):7446\u201352.","journal-title":"J Immunol"},{"issue":"12","key":"543_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/v13122521","volume":"13","author":"PV Da Silva-Neto","year":"2021","unstructured":"Da Silva-Neto PV, de Carvalho JCS, Pimentel VE, P\u00e9rez MM, Toro DM, Fraga-Silva TFC, et al. STREM-1 predicts disease severity and mortality in COVID-19 patients: involvement of peripheral blood leukocytes and MMP-8 activity. Viruses. 2021;13(12):2521.","journal-title":"Viruses"},{"issue":"3","key":"543_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.arr.2010.08.004","volume":"10","author":"D Frasca","year":"2011","unstructured":"Frasca D, Diaz A, Romero M, Landin AM, Blomberg BB. Age effects on B cells and humoral immunity in humans. Ageing Res Rev. 2011;10(3):330\u20135.","journal-title":"Ageing Res Rev"},{"issue":"10","key":"543_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/v13101945","volume":"13","author":"M Tutukina","year":"2021","unstructured":"Tutukina M, Kaznadzey A, Kireeva M, Mazo I. IgG antibodies develop to Spike but not to the nucleocapsid viral protein in many asymptomatic and light COVID-19 cases. Viruses. 2021;13(10):1945.","journal-title":"Viruses"},{"issue":"1","key":"543_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11427-020-1947-y","volume":"65","author":"JY Han","year":"2022","unstructured":"Han JY, Zhang N, Chen DY, Gong YH, Li GL, Kong YX, et al. Distinct durability of IgM\/IgG antibody responses in COVID-19patients with differing severity. Sci China Life Sci. 2022;65(1):223\u20136.","journal-title":"Sci China Life Sci"},{"issue":"10","key":"543_CR11","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.3390\/v13101945","volume":"13","author":"M Trigueros","year":"2021","unstructured":"Trigueros M, Pradenas E, Palac\u00edn D, \u00c1vila-Nieto C, Trinit\u00e9 B, Bonet-Sim\u00f3 JM, et al. Limited immune responses after three months of BNT162b2 vaccine in SARS- CoV-2 uninfected elders living inlong-term care facilities. Viruses. 2021;13(10):1945.","journal-title":"Viruses"},{"issue":"3","key":"543_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10030391","volume":"10","author":"N Suntronwong","year":"2022","unstructured":"Suntronwong N, Yorsaeng R, Puenpa J, Auphimai C, Thongmee T, Vichaiwattana P, et al. COVID-19 breakthrough infection after inactivated vaccine induced robust antibody responses and cross-neutralization of SARS-CoV-2 variants, but less immunity against omicrons. Vaccines. 2022;10(3):391.","journal-title":"Vaccines"},{"issue":"5","key":"543_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41577-022-00809-x","volume":"23","author":"SM Murray","year":"2023","unstructured":"Murray SM, Ansari AM, Frater J, Klenerman P, Dunachie S, Barnes E, et al. The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses. Nat Rev Immunol. 2023;23(5):304\u201316.","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"543_CR14","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1038\/s41596-020-0394-5","volume":"15","author":"JH Nie","year":"2020","unstructured":"Nie JH, Li QQ, Wu JJ, Zhao CY, Hao H, Liu H, et al. Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay. Nat Protoc. 2020;15(11):3699\u2013715.","journal-title":"Nat Protoc"},{"key":"543_CR15","unstructured":"Chinese Center for Disease Control and Prevention. Surveillance data on infectious diseases in China. Available at: https:\/\/www.chinacdc.cn\/jksj\/xgbdyq\/202411\/t20241112_302571.html. (accessed 1\/23\/2023)."},{"issue":"7","key":"543_CR16","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1084\/jem.20111644","volume":"209","author":"H Joo","year":"2012","unstructured":"Joo H, Coquery C, Xue YM, Gayet I, Dillon SR, Punaro M, et al. Serum from patients with SLE instructs monocytes Topromote IgG and IgA plasmablast differentiationy. J Exp Med. 2012;209(7):1335\u201348.","journal-title":"J Exp Med"},{"issue":"38","key":"543_CR17","doi-asserted-by":"publisher","first-page":"E5281","DOI":"10.1073\/pnas.1511270112","volume":"112","author":"B Budeus","year":"2015","unstructured":"Budeus B, Schweigle De Reynoso S, Przekopowitz M, Hoffmann D, Seifert M, K\u00fcppers R. Complexity of the human memory B-cell compartment is determined by the versatility of clonal diversification in germinal centers. Proc Natl Acad Sci U S A. 2015;112(38):E5281-9.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"543_CR18","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","volume":"183","author":"C Rydyznski Moderbacher","year":"2022","unstructured":"Rydyznski Moderbacher C, Ramirez SI, Dan JM, Grifoni A, Hastie KM, Weiskopf D, et al. Antigen-Specific adaptive immunity to SARS-CoV-2 in AcuteCOVID-19 and associations with age and disease severity. Cell. 2022;183(4):996\u2013e101219.","journal-title":"Cell"},{"issue":"7898","key":"543_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","volume":"602","author":"D Planas","year":"2022","unstructured":"Planas D, Saunders N, Maes P, Guivel-Benhassine F, Planchais C, Buchrieser J, et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. 2022;602(7898):671\u20135.","journal-title":"Nature"},{"issue":"5","key":"543_CR20","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1007\/s11357-022-00612-5","volume":"44","author":"J Connors","year":"2022","unstructured":"Connors J, Taramangalam B, Cusimano G, Bell MR, Matt SM, Runner K, et al. Aging alters antiviral signaling pathways resulting in functional impairment in innate immunity in response to pattern recognition receptor agonists. Geroscience. 2022;44(5):2555\u201372.","journal-title":"Geroscience"},{"issue":"12","key":"543_CR21","doi-asserted-by":"publisher","first-page":"11277","DOI":"10.18632\/aging.103524","volume":"12","author":"JO Bock","year":"2020","unstructured":"Bock JO, Ortea I. Re-analysis of SARS-CoV-2-infected host cell proteomics time-course data by impact pathway analysis and network analysis: a potential link with inflammatory response. Aging. 2020;12(12):11277\u201386.","journal-title":"Aging"},{"issue":"6485","key":"543_CR22","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"RH Yan","year":"2020","unstructured":"Yan RH, Zhang YY, Li YN, Xia L, Guo YY, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367(6485):1444\u20138.","journal-title":"Science"},{"issue":"22","key":"543_CR23","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1182\/blood.2020008367","volume":"136","author":"J Perreault","year":"2020","unstructured":"Perreault J, Tremblay T, Fournier MJ, Drouin M, Beaudoin-Bussi\u00e8res G, Pr\u00e9vost J, et al. Waning ofSARS-CoV-2 RBD antibodies in longitudinalconvalescent plasma samples within 4 months after symptom onset. Blood. 2020;136(22):2588\u201391.","journal-title":"Blood"},{"key":"543_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108050","volume":"99","author":"A Hussain","year":"2021","unstructured":"Hussain A, Rafeeq H, Asif HM, Shabbir S, Bilal M, Mulla SI, et al. Current scenario of COVID-19 vaccinations and immune response along with antibody titer in vaccinated inhabitants of different countries. Int Immunopharmacol. 2021;99:108050.","journal-title":"Int Immunopharmacol"},{"key":"543_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-6-1","volume":"6","author":"JD Mellor","year":"2013","unstructured":"Mellor JD, Brown MP, Irving HR, Zalcberg JR, Dobrovic A. A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer. J Hematol Oncol. 2013;6:1.","journal-title":"J Hematol Oncol"},{"issue":"15","key":"543_CR26","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/cid\/ciaa310","volume":"71","author":"L Guo","year":"2020","unstructured":"Guo L, Ren LL, Yang SY, Xiao M, Chang D, Yang F, et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. 2020;71(15):778\u201385.","journal-title":"Clin Infect Dis"},{"issue":"577","key":"543_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf1555","volume":"13","author":"ZJ Wang","year":"2021","unstructured":"Wang ZJ, Lorenzi JCC, Muecksch F, Finkin S, Viant C, Gaebler C, et al. Enhanced SARS-CoV-2 neutralization by dimeric IgA. Sci Transl Med. 2021;13(577):eabf1555.","journal-title":"Sci Transl Med"},{"issue":"10","key":"543_CR28","doi-asserted-by":"publisher","first-page":"5777","DOI":"10.1002\/jmv.27106","volume":"93","author":"R Bag Soytas","year":"2021","unstructured":"Bag Soytas R, Cengiz M, Islamoglu MS, Uysal BB, Ikitimur H, Yavuzer H, et al. Does the COVID-19 seroconversion in older adults resemble the young? J Med Virol. 2021;93(10):5777\u201382.","journal-title":"J Med Virol"},{"issue":"1","key":"543_CR29","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1080\/22221751.2020.1823890","volume":"9","author":"PF Wang","year":"2020","unstructured":"Wang PF, Liu LH, Nair MS, Yin MT, Luo Y, Wang Q, et al. SARS-CoV-2 neutralizing antibody responses are more robust inpatients with severe disease. Emerg Microbes Infect. 2020;9(1):2091\u20133.","journal-title":"Emerg Microbes Infect"},{"issue":"16","key":"543_CR30","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1093\/cid\/ciaa344","volume":"71","author":"JJ Zhao","year":"2020","unstructured":"Zhao JJ, Yuan Q, Wang HY, Liu W, Liao XJ, Su YY, et al. Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. Clin Infect Dis. 2020;71(16):2027\u201334.","journal-title":"Clin Infect Dis"},{"issue":"54","key":"543_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abe0240","volume":"5","author":"K R\u00f6ltgen","year":"2020","unstructured":"R\u00f6ltgen K, Powell AE, Wirz OF, Stevens BA, Hogan CA, Najeeb J, et al. Defining the features and duration of antibody responses toSARS-CoV-2 infection associated with disease severity and outcome. Sci Immunol. 2020;5(54):eabe0240.","journal-title":"Sci Immunol"},{"issue":"48","key":"543_CR32","first-page":"eabc8413","volume":"5","author":"L Premkumar","year":"2005","unstructured":"Premkumar L, Segovia-Chumbez B, Jadi R, Martinez DR, Raut R, Markmann A, et al. The receptor-binding domain of the viral Spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. SciImmunol. 2005;5(48):eabc8413.","journal-title":"SciImmunol"},{"issue":"6","key":"543_CR33","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","volume":"26","author":"QX Long","year":"2020","unstructured":"Long QX, Liu BZ, Deng HJ, Wu GC, Deng kun, Chen YK, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26(6):845\u20138.","journal-title":"Nat Med"},{"issue":"52","key":"543_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abe0367","volume":"5","author":"AS Iyer","year":"2020","unstructured":"Iyer AS, Jones FK, Nodoushani A, Kelly M, Becker M, Slater D, et al. Persistence and decay of human antibody responses to thereceptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci Immunol. 2020;5(52):eabe0367.","journal-title":"Sci Immunol"},{"issue":"8","key":"543_CR35","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","volume":"26","author":"QX Long","year":"2020","unstructured":"Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, et al. Clinical and immunological assessmentof asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26(8):1200\u20134.","journal-title":"Nat Med"},{"issue":"1","key":"543_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19943-y","volume":"11","author":"KN Li","year":"2020","unstructured":"Li KN, Huang B, Wu M, Zhong AF, Li L, Cai Y, et al. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Nat Commun. 2020;11(1):6044.","journal-title":"Nat Commun"},{"issue":"10","key":"543_CR37","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1001\/jamainternmed.2020.4616","volume":"180","author":"F Wu","year":"2020","unstructured":"Wu F, Liu M, Wang AJ, Lu L, Wang QM, Gu CJ, et al. Evaluating the association of clinical characteristics with neutralizing antibody levels in patients who have recovered from mild COVID-19 in Shanghai, China. JAMA Intern Med. 2020;180(10):1356\u201362.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"543_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2022.104979","volume":"24","author":"P Doke","year":"2022","unstructured":"Doke P, Gothankar JS, Doke PP, Kulkarni MM, Khalate KK, Shrivastava S, et al. Time dependent decline of neutralizing antibody titers in COVID-19 patients from Pune, India and evidence of reinfection. Microbes Infect. 2022;24(4):104979.","journal-title":"Microbes Infect"},{"issue":"10","key":"543_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12102052","volume":"12","author":"N Theodorakis","year":"2024","unstructured":"Theodorakis N, Feretzakis G, Hitas C, Kreouzi M, Kalantzi S, Spyridaki A, et al. Immunosenescence: how aging increases susceptibility to bacterial infections and virulence factors. Microorganisms. 2024;12(10):2052.","journal-title":"Microorganisms"},{"issue":"1","key":"543_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91011-x","volume":"11","author":"T Parr","year":"2021","unstructured":"Parr T, Bhat A, Zeidman P, Goel A, Billig AJ, Moran R, et al. Dynamic causal modelling of immune heterogeneity. Sci Rep. 2021;11(1):11400.","journal-title":"Sci Rep"},{"issue":"1","key":"543_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47451-w","volume":"15","author":"J Pu\u0161nik","year":"2024","unstructured":"Pu\u0161nik J, Zorn J, Monzon-Posadas WO, Peters K, Osypchuk E, Blaschke S, et al. Vaccination impairs de novo immune response to Omicron breakthrough infection, a precondition for the original antigenic sin. Nat Commun. 2024;15(1):3102.","journal-title":"Nat Commun"},{"key":"543_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1150667","volume":"14","author":"M Bormann","year":"2023","unstructured":"Bormann M, Brochhagen L, Alt M, Otte M, Th\u00fcmmler L, van de Sand L, et al. Immune responsesin COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5. Front Immunol. 2023;14:1150667.","journal-title":"Front Immunol"},{"issue":"12","key":"543_CR43","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1021\/acs.jproteome.2c00514","volume":"21","author":"E Forte","year":"2022","unstructured":"Forte E, Des Soye BJ, Melani RD, Hollas MAR, Kafader JO, Sha BE, et al. Divergent antibody repertoires found for Omicron versus Wuhan SARS-CoV-2 strains using Ig-MS. J Proteome Res. 2022;21(12):2987\u201397.","journal-title":"J Proteome Res"},{"issue":"12","key":"543_CR44","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41590-020-00814-z","volume":"21","author":"MC Woodruff","year":"2020","unstructured":"Woodruff MC, Ramonell RP, Nguyen DC, Cashman KS, Saini AS, Haddad NS, et al. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat Immunol. 2020;21(12):1506\u201316.","journal-title":"Nat Immunol"},{"issue":"6","key":"543_CR45","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.immuni.2020.11.006","volume":"53","author":"RA Elsner","year":"2020","unstructured":"Elsner RA, Shlomchik MJ. Germinal center and extrafollicular B cell responses in vaccination, immunity, and autoimmunity. Immunity. 2020;53(6):1136\u201350.","journal-title":"Immunity"},{"issue":"1","key":"543_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39734-5","volume":"14","author":"JH Lam","year":"2023","unstructured":"Lam JH, Baumgarth N. Toll-like receptor mediated inflammation directs B cells towards protective antiviral extrafollicular responses. Nat Commun. 2023;14(1):3979.","journal-title":"Nat Commun"},{"issue":"2","key":"543_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/v14020203","volume":"14","author":"M M\u00fcller","year":"2022","unstructured":"M\u00fcller M, Volzke J, Subin B, Schmidt CJ, Geerdes-Fenge H, Reisinger EC, et al. Distinguishing incubation and acute disease stagesof mild-to-moderate COVID-19. Viruses. 2022;14(2):203.","journal-title":"Viruses"},{"issue":"2","key":"543_CR48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41584-020-00544-4","volume":"17","author":"S Fillatreau","year":"2021","unstructured":"Fillatreau S, Manfroi B, D\u00f6rner T. Toll-like receptorsignalling in B cells during systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(2):98\u2013108.","journal-title":"Nat Rev Rheumatol"},{"key":"543_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00427","volume":"9","author":"S Malkiel","year":"2018","unstructured":"Malkiel S, Barlev AN, Atisha-Fregoso Y, Suurmond J, Diamond B. Plasma cell differentiation pathways in systemic lupus erythematosus. Front Immunol. 2018;9:427.","journal-title":"Front Immunol"},{"issue":"4","key":"543_CR50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jaut.2007.07.015","volume":"29","author":"ZH Zhou","year":"2007","unstructured":"Zhou ZH, Tzioufas AG, Notkins AL. Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J Autoimmun. 2007;29(4):219\u201328.","journal-title":"J Autoimmun"},{"issue":"3","key":"543_CR51","doi-asserted-by":"publisher","first-page":"00919","DOI":"10.1183\/23120541.00919-2023","volume":"10","author":"SP Cass","year":"2024","unstructured":"Cass SP, Nicolau DV Jr, Baker JR, Mwasuku C, Ramakrishnan S, Mahdi M, et al. Coordinated nasal mucosa-mediated immunity accelerates recovery from COVID-19. ERJ Open Res. 2024;10(3):00919\u20132023.","journal-title":"ERJ Open Res"},{"issue":"577","key":"543_CR52","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd2223","volume":"13","author":"D Sterlin","year":"2021","unstructured":"Sterlin D, Mathian A, Miyara M, Mohr A, Anna F, Cla\u00ebr L, et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med. 2021;13(577):eabd2223.","journal-title":"Sci Transl Med"},{"issue":"1","key":"543_CR53","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","volume":"74","author":"ZS Wallace","year":"2015","unstructured":"Wallace ZS, Mattoo H, Carruthers M, Mahajan VS, Della Torre E, Lee H, et al. Plasmablasts as a biomarker forIgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74(1):190\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"543_CR54","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","volume":"382","author":"Q Li","year":"2020","unstructured":"Li Q, Guan XH, Wu P, Wang XY, Zhou L, Tong YQ, et al. Early transmission dynamics in Wuhan, China, of novel Coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199\u2013207.","journal-title":"N Engl J Med"},{"key":"543_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.988125","volume":"13","author":"MJ Castleman","year":"2022","unstructured":"Castleman MJ, Stumpf MM, Therrien NR, Smith MJ, Lesteberg KE, Palmer BE, et al. Autoantibodies elicited with SARS-CoV-2 infectionare linked toalterations in double negative B cells. Front Immunol. 2022;13:988125.","journal-title":"Front Immunol"},{"key":"543_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1034159","volume":"13","author":"P Chattopadhyay","year":"2022","unstructured":"Chattopadhyay P, Khare K, Kumar M, Mishra P, Anand A, Maurya R, et al. Single-cell multiomicsrevealed the dynamics of antigen presentation, immune response and T cell activation in the COVID-19 positive and recovered individuals. Front Immunol. 2022;13:1034159.","journal-title":"Front Immunol"},{"issue":"12","key":"543_CR57","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1593\/neo.05448","volume":"7","author":"A Pinzon-Charry","year":"2005","unstructured":"Pinzon-Charry A, Maxwell T, Prato S, Furnival C, Schmidt C, L\u00f3pez JA. HLA-DR+ immature cellsexhibit reduced antigen-presenting cell function but respond to CD40 stimulation. Neoplasia. 2005;7(12):1123\u201332.","journal-title":"Neoplasia"},{"issue":"1","key":"543_CR58","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140491","volume":"131","author":"JK Files","year":"2021","unstructured":"Files JK, Boppana S, Perez MD, Sarkar S, Lowman KE, Qin K, et al. Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection. J Clin Invest. 2021;131(1):e140491.","journal-title":"J Clin Invest"}],"container-title":["Immunity & Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-025-00543-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12979-025-00543-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-025-00543-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T12:04:37Z","timestamp":1762257877000},"score":1,"resource":{"primary":{"URL":"https:\/\/immunityageing.biomedcentral.com\/articles\/10.1186\/s12979-025-00543-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["543"],"URL":"https:\/\/doi.org\/10.1186\/s12979-025-00543-7","relation":{},"ISSN":["1742-4933"],"issn-type":[{"type":"electronic","value":"1742-4933"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}